180 related articles for article (PubMed ID: 35682709)
21. The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression.
Cheriyamundath S; Kumar A; Gavert N; Brabletz T; Ben-Ze'ev A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805564
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
23. PLOD2 regulated by transcription factor FOXA1 promotes metastasis in NSCLC.
Du H; Chen Y; Hou X; Huang Y; Wei X; Yu X; Feng S; Wu Y; Zhan M; Shi X; Lin S; Lu L; Yuan S; Sun L
Cell Death Dis; 2017 Oct; 8(10):e3143. PubMed ID: 29072684
[TBL] [Abstract][Full Text] [Related]
24. [Upregulation of PLOD2 promotes invasion and metastasis of osteosarcoma cells].
Cao F; Kang XH; Cui YH; Wang Y; Zhao KL; Wang YN; Kou WZ; Miao ZH; Cao XJ
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):435-440. PubMed ID: 31216829
[No Abstract] [Full Text] [Related]
25. PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway.
Lan J; Zhang S; Zheng L; Long X; Chen J; Liu X; Zhou M; Zhou J
Cancer Sci; 2023 Aug; 114(8):3190-3202. PubMed ID: 37227305
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
Bi Y; Wu ZH; Cao F
BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
[TBL] [Abstract][Full Text] [Related]
27. Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma.
Dumitru CA; Schröder H; Schäfer FTA; Aust JF; Kreße N; Siebert CLR; Stein KP; Haghikia A; Wilkens L; Mawrin C; Sandalcioglu IE
Cells; 2023 Oct; 12(20):. PubMed ID: 37887342
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.
Wang Z; Shi Y; Ying C; Jiang Y; Hu J
Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
30. Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma.
Dumitru CA; Brouwer E; Stelzer T; Nocerino S; Rading S; Wilkens L; Sandalcioglu IE; Karsak M
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071761
[TBL] [Abstract][Full Text] [Related]
31. Involvement of microRNA-124 in biological behaviors of laryngeal carcinoma via PLOD2 signaling pathway.
Huang J; Zhou XH; Huang S; Li S; Wu TT
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4855-4862. PubMed ID: 32432748
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
33. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
34. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
35. A hierarchical network of hypoxia-inducible factor and SMAD proteins governs procollagen lysyl hydroxylase 2 induction by hypoxia and transforming growth factor β1.
Rosell-García T; Palomo-Álvarez O; Rodríguez-Pascual F
J Biol Chem; 2019 Sep; 294(39):14308-14318. PubMed ID: 31391253
[TBL] [Abstract][Full Text] [Related]
36. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
37. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
[TBL] [Abstract][Full Text] [Related]
38. Apelin promotes osteosarcoma metastasis by upregulating PLOD2 expression via the Hippo signaling pathway and hsa_circ_0000004/miR-1303 axis.
Trang NTN; Lai CY; Tsai HC; Huang YL; Liu SC; Tsai CH; Fong YC; Tzeng HE; Tang CH
Int J Biol Sci; 2023; 19(2):412-425. PubMed ID: 36632453
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
40. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
Huang QR; Li JW; Pan XB
Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]